{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:59:49Z","timestamp":1790888389082,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T00:00:00Z","timestamp":1587254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T00:00:00Z","timestamp":1587254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013093","name":"Science and Technology Planning Project of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20160428175005906"],"award-info":[{"award-number":["JCYJ20160428175005906"]}],"id":[{"id":"10.13039\/501100013093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013093","name":"Science and Technology Planning Project of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20180228162311024"],"award-info":[{"award-number":["JCYJ20180228162311024"]}],"id":[{"id":"10.13039\/501100013093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Accurate identification Candida is important for successful therapy and epidemiology study. The aim of research is to study API 20C yeast identification system identification rate by using molecular identification as gold standard and tested the antifungal susceptibility of Candida from patients with vulvovaginal candidiasis (VVC).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In total, 3574 yeast isolates were obtained from patients with VVC. API 20C yeast identification, molecular identification and in vitro antifungal susceptibility were performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p><jats:italic>C. albicans<\/jats:italic> was the predominant Candida species [2748 isolates, 76.9%] in VVC. The isolates from vaginal samples represented 22 species based on molecular identification. The API 20C system identifies only 11 of the species encountered during the study period. Based on the API 20C system, 3273 (91.58%) isolates were correctly identified to the species level. The correct identification rate of the API 20C system for rare yeast was 15.29% (26\/170 isolates). Antifungal susceptibility was tested in a total of 1844 isolates of Candida from patients with VVC. <jats:italic>C. albicans<\/jats:italic> was susceptible to most of the tested antifungals. The MICs of azoles for <jats:italic>C. glabrata<\/jats:italic> were higher than those for <jats:italic>C. albicans<\/jats:italic>. The MICs of echinocandins for <jats:italic>C. parapsilosis<\/jats:italic> were higher than those for <jats:italic>C. albicans<\/jats:italic>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The API 20C yeast identification system can be used to reliably identify the most common Candida species while molecular methods are necessary for the identification of closely related, emerging, and rare yeast species. The results from this study suggest that much of the previous studies on the epidemiology of VVC should be re-thought. <jats:italic>C. albicans<\/jats:italic> was susceptible to most of the tested antifungals.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-020-04985-w","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T15:04:18Z","timestamp":1589209458000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis"],"prefix":"10.1186","volume":"20","author":[{"given":"Yu","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangrong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiheng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,19]]},"reference":[{"issue":"RR-03","key":"4985_CR1","first-page":"1","volume":"64","author":"KA Workowski","year":"2015","unstructured":"Workowski KA, Bolan GA. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-03):1\u2013137.","journal-title":"MMWR Recomm Rep"},{"issue":"9","key":"4985_CR2","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.annepidem.2017.08.010","volume":"27","author":"F Blostein","year":"2017","unstructured":"Blostein F, Levin-Sparenberg E, Wagner J, Foxman B. Recurrent vulvovaginal candidiasis. Ann Epidemiol. 2017;27(9):575\u201382 e3.","journal-title":"Ann Epidemiol"},{"issue":"2","key":"4985_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.mycmed.2014.01.060","volume":"24","author":"XP Liu","year":"2014","unstructured":"Liu XP, Fan SR, Peng YT, Zhang HP. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in southern China from 2003 to 2012. J Mycol Med. 2014;24(2):106\u201311.","journal-title":"J Mycol Med"},{"issue":"10","key":"4985_CR4","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.4103\/0366-6999.181964","volume":"129","author":"FJ Wang","year":"2016","unstructured":"Wang FJ, Zhang D, Liu ZH, Wu WX, Bai HH, Dong HY. Species distribution and in vitro antifungal susceptibility of vulvovaginal Candida isolates in China. Chin Med J. 2016;129(10):1161\u20135.","journal-title":"Chin Med J"},{"issue":"11","key":"4985_CR5","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1111\/tmi.12577","volume":"20","author":"KP Ng","year":"2015","unstructured":"Ng KP, Kuan CS, Kaur H, Na SL, Atiya N, Velayuthan RD. Candida species epidemiology 2000-2013: a laboratory-based report. Tropical Med Int Health. 2015;20(11):1447\u201353.","journal-title":"Tropical Med Int Health"},{"issue":"6","key":"4985_CR6","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3109\/1040841X.2015.1091805","volume":"42","author":"B Gon\u00e7alves","year":"2016","unstructured":"Gon\u00e7alves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S. Vulvovaginal candidiasis: epidemiology, microbiology and risk factors. Crit Rev Microbiol. 2016;42(6):905\u201327.","journal-title":"Crit Rev Microbiol"},{"issue":"8","key":"4985_CR7","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1128\/JCM.00802-15","volume":"53","author":"B Posteraro","year":"2015","unstructured":"Posteraro B, Efremov L, Leoncini E, Amore R, Posteraro P, Ricciardi W, Sanguinetti M. Are the conventional commercial yeast identification methods still helpful in the era of new clinical microbiology diagnostics? A meta-analysis of their accuracy. J Clin Microbiol. 2015;53(8):2439\u201350.","journal-title":"J Clin Microbiol"},{"key":"4985_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.mimet.2015.02.004","volume":"111","author":"G Criseo","year":"2015","unstructured":"Criseo G, Scordino F, Romeo O. Current methods for identifying clinically important cryptic Candida species. J Microbiol Methods. 2015;111:50\u20136.","journal-title":"J Microbiol Methods"},{"issue":"6","key":"4985_CR9","first-page":"488","volume":"17","author":"RA Sobel JDand Akins","year":"2015","unstructured":"Sobel JDand Akins RA. The role of PCR in the diagnosis of Candida vulvovaginitis-a new gold standard? Curr Infect Dis Rep. 2015;17(6):488.","journal-title":"Curr Infect Dis Rep"},{"issue":"9","key":"4985_CR10","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1080\/14656566.2018.1476490","volume":"19","author":"R Sobel JDand Sobel","year":"2018","unstructured":"Sobel JDand Sobel R. Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species. Expert Opin Pharmacother. 2018;19(9):971\u20137.","journal-title":"Expert Opin Pharmacother"},{"issue":"11","key":"4985_CR11","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1016\/S1473-3099(18)30103-8","volume":"18","author":"DW Denning","year":"2018","unstructured":"Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 2018;18(11):e339\u201347.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"4985_CR12","doi-asserted-by":"publisher","first-page":"624.e1","DOI":"10.1016\/j.ajog.2018.03.001","volume":"218","author":"SR Brand","year":"2018","unstructured":"Brand SR, Degenhardt TP, Person K, Sobel JD, Nyirjesy P, Schotzinger RJ, Tavakkol A. A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 2018;218(6):624.e1\u20139.","journal-title":"Am J Obstet Gynecol."},{"issue":"9","key":"4985_CR13","doi-asserted-by":"publisher","first-page":"5567","DOI":"10.1128\/AAC.00185-15","volume":"59","author":"EP Garvey","year":"2015","unstructured":"Garvey EP, Hoekstra WJ, Schotzinger RJ, Sobel JD, Lilly EA, Fidel PL Jr. Efficacy of the clinical agent VT-1161 against fluconazole-sensitive and -resistant Candida albicans in a murine model of vaginal candidiasis. Antimicrob Agents Chemother. 2015;59(9):5567\u201373.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"4985_CR14","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1093\/jac\/dkx008","volume":"72","author":"DA Boikov","year":"2017","unstructured":"Boikov DA, Locke JB, James KD, Bartizal K, Sobel JD. In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis. J Antimicrob Chemother. 2017;72(5):1355\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"4985_CR15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/LGT.0000000000000473","volume":"23","author":"P Nyirjesy","year":"2019","unstructured":"Nyirjesy P, Alessio C, Jandourek A, Lee JD, Sandison T. Sobel JD.CD101 topical compared with oral fluconazole for acute vulvovaginal candidiasis: a randomized controlled trial. J Low Genit Tract Dis. 2019;23(3):226\u20139.","journal-title":"J Low Genit Tract Dis"},{"issue":"6","key":"4985_CR16","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1093\/mmy\/myu003","volume":"52","author":"Y Shan","year":"2014","unstructured":"Shan Y, Fan S, Liu X, Li J. Prevalence of Candida albicans-closely related yeasts, Candida africana and Candida dubliniensis, in vulvovaginal candidiasis. Med Mycol. 2014;52(6):636\u201340.","journal-title":"Med Mycol"},{"issue":"3\u20134","key":"4985_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11046-014-9800-2","volume":"178","author":"J Li","year":"2014","unstructured":"Li J, Shan Y, Fan S, Liu X. Prevalence of Candida nivariensis and Candida bracarensis in vulvovaginal candidiasis. Mycopathologia. 2014;178(3\u20134):279\u201383.","journal-title":"Mycopathologia"},{"issue":"11","key":"4985_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142880","volume":"10","author":"M Asadzadeh","year":"2015","unstructured":"Asadzadeh M, Ahmad S, Hagen F, Meis JF, Al-Sweih N, Khan Z. Simple, low-cost detection of Candida parapsilosis complex isolates and molecular fingerprinting of Candida orthopsilosis strains in Kuwait by ITS region sequencing and amplified fragment length polymorphism analysis. PLoS One. 2015;10(11):e0142880.","journal-title":"PLoS One"},{"issue":"3","key":"4985_CR19","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1128\/JCM.44.3.693-699.2006","volume":"44","author":"SN Leaw","year":"2006","unstructured":"Leaw SN, Chang HC, Sun HF, Barton R, Bouchara JP, Chang TC. Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions. J Clin Microb. 2006;44(3):693\u20139.","journal-title":"J Clin Microb"},{"key":"4985_CR20","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; third edition; CLSI document M27-A3","author":"CLSI","year":"2008","unstructured":"CLSI. Reference method for broth dilution antifungal susceptibility testing of yeasts; third edition; CLSI document M27-A3. Wayne: Clinical and Laboratory Standards Institute; 2008."},{"key":"4985_CR21","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; 1st ed, M60","author":"CLSI","year":"2017","unstructured":"CLSI. Reference method for broth dilution antifungal susceptibility testing of yeasts; 1st ed, M60. Wayne: Clinical and Laboratory Standards Institute; 2017."},{"issue":"8","key":"4985_CR22","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1128\/JCM.00913-12","volume":"50","author":"AM Borman","year":"2012","unstructured":"Borman AM, Szekely A, Palmer MD, Johnson EM. Assessment of accuracy of identification of pathogenic yeasts in microbiology laboratories in the United Kingdom. J Clin Microbiol. 2012;50(8):2639\u201344.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"4985_CR23","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/mmy\/myt036","volume":"52","author":"MT Dur\u00e1n-Valle","year":"2014","unstructured":"Dur\u00e1n-Valle MT, Sanz-Rodr\u00edguez N, Mu\u00f1oz-Para\u00edso C, Almagro-Molt\u00f3 M, G\u00f3mez-Garc\u00e9s JL. Identification of clinical yeasts by Vitek MS system compared with API ID 32 C. Med Mycol. 2014;52(4):342\u20139.","journal-title":"Med Mycol"},{"issue":"12","key":"4985_CR24","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1099\/0022-1317-50-12-1105","volume":"50","author":"SG G\u00fcnde\u015f","year":"2002","unstructured":"G\u00fcnde\u015f SG, Gulenc S, Bingol R. Comparative performance of Fungichrom I, Candifast and API 20C aux systems in the identification of clinically significant yeasts. J Med Microbiol. 2002;50(12):1105\u201310.","journal-title":"J Med Microbiol"},{"key":"4985_CR25","doi-asserted-by":"crossref","unstructured":"Arastehfar A, Daneshnia F, Kord M, Roudbary M, Zarrinfar H, Fang W, Najafzadeh MJ, Khodavaisy S, Pan W, Liao W, Badali H, Rezaie S, Zomorodian K, Hagen F, Boekhout T. Comparison of 21-plex PCR and API 20C AUX, MALDI-TOF MS, and rDNA sequencing for a wide range of clinically isolated yeast species: improved identification by combining 21-plex PCR and API 20C AUX as an alternative strategy for developing countries. Front Cell Infect Microbiol. 2019;9:21.","DOI":"10.3389\/fcimb.2019.00176"},{"issue":"1\u20132","key":"4985_CR26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11046-014-9821-x","volume":"179","author":"Y Zhu","year":"2015","unstructured":"Zhu Y, Shan Y, Fan S, Li J, Liu X. Candida parapsilosis sensu stricto and the closely related species Candida orthopsilosis and Candida metapsilosis in vulvovaginal candidiasis. Mycopathologia. 2015;179(1\u20132):111\u20138.","journal-title":"Mycopathologia"},{"issue":"6","key":"4985_CR27","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3109\/13693786.2012.662597","volume":"50","author":"A Kalkanci","year":"2012","unstructured":"Kalkanci A, G\u00fczel AB, Khalil II, Aydin M, Ilkit M, Ku\u015ftimur S. Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors. Med Mycol. 2012;50(6):585\u201393.","journal-title":"Med Mycol"},{"issue":"4","key":"4985_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/jof4040121","volume":"4","author":"O Makanjuola","year":"2018","unstructured":"Makanjuola O, Bongomin F, Fayemiwo SA. An update on the roles of non-albicans candida species in vulvovaginitis. J Fungi (Basel). 2018;4(4):121.","journal-title":"J Fungi (Basel)"},{"issue":"3","key":"4985_CR29","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1093\/jac\/dku460","volume":"70","author":"M Xiao","year":"2015","unstructured":"Xiao M, Fan X, Chen SC, Wang H, Sun ZY, Liao K, Chen SL, Yan Y, Kang M, Hu ZD, Chu YZ, Hu TS, Ni YX, Zou GL, Kong F, Xu YC. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance. J Antimicrob Chemother. 2015;70(3):802\u201310.","journal-title":"J Antimicrob Chemother"},{"key":"4985_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijid.2014.12.033","volume":"33","author":"L Zhang","year":"2015","unstructured":"Zhang L, Zhou S, Pan A, Li J, Liu B. Surveillance of antifungal susceptibilities in clinical isolates of Candida species at 36 hospitals in China from 2009 to 2013. Int J Infect Dis. 2015;33:1\u20134.","journal-title":"Int J Infect Dis"},{"key":"4985_CR31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.drup.2015.10.001","volume":"23","author":"D Delarze Eand Sanglard","year":"2015","unstructured":"Delarze Eand Sanglard D. Defining the frontiers between antifungal resistance, tolerance and the concept of persistence. Drug Resist Updat. 2015;23:12\u20139.","journal-title":"Drug Resist Updat"},{"key":"4985_CR32","doi-asserted-by":"crossref","unstructured":"Castanheira M, Deshpande LM, Davis AP, Rhomberg PR, Pfaller MA. Monitoring antifungal resistance in a global collection of invasive yeasts and molds: application of CLSI epidemiological cutoff values and whole-genome sequencing analysis for detection of azole resistance in Candida albicans. Antimicrob Agents Chemother. 2017;61(10):e00906\u201317.","DOI":"10.1128\/AAC.00906-17"},{"issue":"2","key":"4985_CR33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jiac.2015.08.008","volume":"22","author":"M Nagashima","year":"2016","unstructured":"Nagashima M, Yamagishi Y, Mikamo H. Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis. J Infect Chemother. 2016;22(2):124\u20136.","journal-title":"J Infect Chemother"},{"issue":"6","key":"4985_CR34","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1097\/AOG.0b013e31827307b2","volume":"120","author":"D Marchaim","year":"2012","unstructured":"Marchaim D, Lemanek L, Bheemreddy S, Kaye KS, Sobel JD. Fluconazole-resistant Candida albicans vulvovaginitis. Obstet Gynecol. 2012;120(6):1407\u201314.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"4985_CR35","first-page":"103","volume":"72","author":"S Bailly","year":"2016","unstructured":"Bailly S, Maubon D, Fournier P, Pelloux H, Schwebel C, Chapuis C, Foroni L, Cornet M, Timsit JF. Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. - trends over 10 years. J Inf Secur. 2016;72(1):103\u201311.","journal-title":"J Inf Secur"},{"issue":"1","key":"4985_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1439-0507.2009.01752.x","volume":"54","author":"CC Bulik","year":"2011","unstructured":"Bulik CC, Sobel JD, Nailor MD. Susceptibility profile of vaginal isolates of Candida albicans prior to and following fluconazole introduction - impact of two decades. Mycoses. 2011;54(1):34\u20138.","journal-title":"Mycoses"},{"issue":"2","key":"4985_CR37","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.bjm.2016.01.005","volume":"47","author":"G Fornari","year":"2016","unstructured":"Fornari G, Vicente VA, Gomes RR, Muro MD, Pinheiro RL, Ferrari C, Herkert PF, Takimura M, Carvalho NS, Queiroz-Telles F. Susceptibility and molecular characterization of Candida species from patients with vulvovaginitis. Braz J Microbiol. 2016;47(2):373\u201380..","journal-title":"Braz J Microbiol"},{"issue":"Pt 4","key":"4985_CR38","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1099\/jmm.0.000024","volume":"64","author":"XY Shi","year":"2015","unstructured":"Shi XY, Yang YP, Zhang Y, Li W, Wang JD, Huang WM, Fan YM. Molecular identification and antifungal susceptibility of 186 Candida isolates from vulvovaginalcandidiasis in southern China. J Med Microbiol. 2015;64(Pt 4):390\u20133.","journal-title":"J Med Microbiol"},{"issue":"4","key":"4985_CR39","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/00045391-200607000-00010","volume":"13","author":"A Ferahbas","year":"2006","unstructured":"Ferahbas A, Koc AN, Uksal U, Aygen E, Mistik S, Yildiz S. Terbinafine versus itraconazole and fluconazole in the treatment of vulvovaginal candidiasis. Am J Ther. 2006;13(4):332\u20136.","journal-title":"Am J Ther"}],"updated-by":[{"DOI":"10.1186\/s12879-021-06601-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000}}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-04985-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-04985-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-04985-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T13:10:14Z","timestamp":1643029814000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-04985-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,19]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4985"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-04985-w","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12879-021-06601-x","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,19]]},"assertion":[{"value":"22 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12879-021-06601-x","URL":"https:\/\/doi.org\/10.1186\/s12879-021-06601-x","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The verbal informed consents were obtained from all individual participants included in the study. The study and the informed consents procedure were approved by Peking University Shenzhen Hospital Medical Ethics Committee (20140406).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"287"}}